Advocacy

Supporting Access to Genetic Counseling

Supporting Access to Genetic Counseling

Genetic counselors are a key part of the delivery of genetic testing in healthcare across the United States, and it is essential that their services are accessible to patients. ASHG strongly supports the Access to Genetic Counselor Services Act. Related: ASHG News: H.R. 7083: Improving Access to Genetic Counseling (December 2018) Letter to House Leaders... Read More

Preventing Sexual Harassment in Science

Preventing Sexual Harassment in Science

ASHG supports policies that enable a productive and safe working environment for all scientific professionals. The Society is committed to promoting a harassment-free workplace for geneticists, and believes that science can only achieve its goals when we are able to fully engage the minds, talent, and perspectives of all who wish to participate. Related: Letter... Read More

Prohibiting Genetic Discrimination

Prohibiting Genetic Discrimination

Protections against genetic discrimination advance genetics research and the clinical use of genetics, as well as ensure the ethical use of genetic data. Ten years after the passage of the Genetic Information Nondiscrimination Act (GINA), ASHG remains a staunch advocate for GINA’s strong implementation and for other laws that enhance protections for the public. Related:... Read More

Protecting Genetic Privacy of Immigrant Families

Protecting Genetic Privacy of Immigrant Families

In 2018, a legislative amendment was proposed that would protect the genetic privacy of immigrant families by restricting the use of their genetic material and data to helping reunify family members. The amendment would require that government officials restrict their use of DNA analysis to when it is truly needed and ensure that biological samples... Read More

Advancing Evidence-Based Genetic Testing

Advancing Evidence-Based Genetic Testing

In 2018, the U.S. Food and Drug Administration (FDA) invited comments on its intention to exempt a list of class II devices from premarket notification requirements, including tests assessing genetic health risks. ASHG responded to this request for comment by outlining its support for regulation that brings scientifically valid, evidence-based tests to market, and expressing... Read More